Adherence Trial With MS LifeLines ® Services

TerminatedOBSERVATIONAL
Enrollment

306

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Multiple SclerosisRelapsing-Remitting
Interventions
OTHER

Standard Services of Group A (Group A1)

Support services provided in this group will include: Initial field nurse injection training visit; field nurse follow-up and subsequent visits; and follow-up phone calls at periodic intervals

OTHER

Customized Services of Group A (Group A2)

In addition to the initial field nurse injection training visit and follow-up call, subjects will select from support services including field nurse follow-up visits; follow-up phone calls; email and/or text reminders; subject self-assessment and use of treatment planning tools; and mail/e-mail educational materials.

OTHER

Group B

Support services provided in this group will include initial field nurse injection training visit and follow-up phone calls at periodic intervals.

Trial Locations (1)

Unknown

Call EMD Serono Medical Information for information on recruiting sites, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT01905527 - Adherence Trial With MS LifeLines ® Services | Biotech Hunter | Biotech Hunter